86 related articles for article (PubMed ID: 11694645)
1. Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model.
Emenaker NJ; Calaf GM; Cox D; Basson MD; Qureshi N
J Nutr; 2001 Nov; 131(11 Suppl):3041S-6S. PubMed ID: 11694645
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Butyrate to Inhibit Colonic Cancer Cell Growth Is Cell Type-Specific and Apoptosis-Dependent.
Oncel S; Safratowich BD; Lindlauf JE; Liu Z; Palmer DG; Briske-Anderson M; Zeng H
Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398853
[TBL] [Abstract][Full Text] [Related]
3. The Level Short Chain Fatty Acids and HSP 70 in Colorectal Cancer and Non-Colorectal Cancer.
Yusuf F; Adewiah S; Fatchiyah F
Acta Inform Med; 2018 Oct; 26(3):160-163. PubMed ID: 30515005
[TBL] [Abstract][Full Text] [Related]
4. Total saponins from Lilium lancifolium: a promising alternative to inhibit the growth of gastric carcinoma cells.
Zhang YY; Luo LM; Wang YX; Zhu N; Zhao TJ; Qin L
J Cancer; 2020; 11(14):4261-4273. PubMed ID: 32368309
[No Abstract] [Full Text] [Related]
5. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.
Bach Knudsen KE; Lærke HN; Hedemann MS; Nielsen TS; Ingerslev AK; Gundelund Nielsen DS; Theil PK; Purup S; Hald S; Schioldan AG; Marco ML; Gregersen S; Hermansen K
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30322146
[TBL] [Abstract][Full Text] [Related]
6. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men.
van der Beek CM; Canfora EE; Kip AM; Gorissen SHM; Olde Damink SWM; van Eijk HM; Holst JJ; Blaak EE; Dejong CHC; Lenaerts K
Metabolism; 2018 Oct; 87():25-35. PubMed ID: 29953876
[TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate has anti-proliferative, pro-differentiating, and immunomodulatory effects in osteosarcoma cells and counteracts the TNFα-induced low-grade inflammation.
Perego S; Sansoni V; Banfi G; Lombardi G
Int J Immunopathol Pharmacol; 2018; 32():394632017752240. PubMed ID: 29363375
[TBL] [Abstract][Full Text] [Related]
8. Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance.
McNabney SM; Henagan TM
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29231905
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
10. Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells.
Zeng H; Taussig DP; Cheng WH; Johnson LK; Hakkak R
Nutrients; 2017 Jan; 9(1):. PubMed ID: 28045428
[TBL] [Abstract][Full Text] [Related]
11. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine.
Gadaleta RM; Oldenburg B; Willemsen EC; Spit M; Murzilli S; Salvatore L; Klomp LW; Siersema PD; van Erpecum KJ; van Mil SW
Biochim Biophys Acta; 2011 Aug; 1812(8):851-8. PubMed ID: 21540105
[TBL] [Abstract][Full Text] [Related]
12. NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota.
Niño-Narvión J; Rojo-López MI; Martinez-Santos P; Rossell J; Ruiz-Alcaraz AJ; Alonso N; Ramos-Molina B; Mauricio D; Julve J
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447318
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of Microbiota Commensals and Their Bacteriocins for Therapeutics.
Hols P; Ledesma-García L; Gabant P; Mignolet J
Trends Microbiol; 2019 Aug; 27(8):690-702. PubMed ID: 30987817
[TBL] [Abstract][Full Text] [Related]
14. Sodium Phenylbutyrate Ameliorates Inflammatory Response Induced by
Wang X; Zhang M; Jiang N; Zhang A
Molecules; 2018 Nov; 23(12):. PubMed ID: 30469547
[TBL] [Abstract][Full Text] [Related]
15.
Martin G; Kolida S; Marchesi JR; Want E; Sidaway JE; Swann JR
Front Microbiol; 2018; 9():1153. PubMed ID: 29922256
[TBL] [Abstract][Full Text] [Related]
16. Commensal Bacteria-Dependent CD8αβ
Chen B; Ni X; Sun R; Zeng B; Wei H; Tian Z; Wei H
Front Immunol; 2018; 9():1065. PubMed ID: 29868024
[TBL] [Abstract][Full Text] [Related]
17. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Khan MT; Bäckhed F; Marschall HU
J Lipid Res; 2017 Feb; 58(2):412-419. PubMed ID: 27956475
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System.
Obata Y; Pachnis V
Gastroenterology; 2016 Nov; 151(5):836-844. PubMed ID: 27521479
[TBL] [Abstract][Full Text] [Related]
19. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review.
Rutayisire E; Huang K; Liu Y; Tao F
BMC Gastroenterol; 2016 Jul; 16(1):86. PubMed ID: 27475754
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
